NeuroOne Medical Technologies Corporation (NMTC)

NMTC Income Statement

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	9.72	12.1	3.45	3.41	2.12	0.24
Revenue Growth (YoY)	10.98%	250.35%	1.33%	60.73%	772.60%	-87.39%
Cost of Revenue	4.42	3.96	2.37	1.5	0.24	0.28
Gross Profit	5.3	8.14	1.08	1.91	1.88	-0.03
Selling, General & Admin	7.21	7.38	7.9	6.93	6.98	6.26
Research & Development	5.16	4.98	5.07	6.94	4.93	3.93
Total Operating Expenses	12.36	12.37	12.97	13.87	11.91	10.19
Operating Income	-7.07	-4.23	-11.89	-11.96	-10.03	-10.22
Interest Expense	-	-	-	-	-	-0
Other Non-Operating Income (Expense)	0.42	0.62	-0.43	0.1	0.03	0.27
Total Non-Operating Income (Expense)	0.42	0.62	-0.43	0.1	0.03	0.27
Pretax Income	-6.64	-3.61	-12.32	-11.86	-10	-9.95
Net Income	-6.64	-3.61	-12.32	-11.86	-10	-9.95
Net Income to Common	-6.64	-3.61	-12.32	-11.86	-10	-9.95
Shares Outstanding (Basic)	8	7	4	3	3	2
Shares Outstanding (Diluted)	8	7	4	3	3	2
Shares Change (YoY)	67.77%	50.03%	47.69%	13.27%	49.56%	97.52%
EPS (Basic)	-0.85	-0.54	-2.76	-3.90	-3.78	-5.58
EPS (Diluted)	-0.85	-0.54	-2.76	-3.90	-3.78	-5.58
Shares Outstanding	8.62	8.33	5.14	3.99	2.7	2
Free Cash Flow	-7.57	-2.92	-11.13	-13.27	-7.79	-8.67
Free Cash Flow Per Share	-0.91	-0.44	-2.50	-4.39	-2.92	-4.86
Gross Margin	54.50%	67.30%	31.27%	56.10%	88.59%	-13.56%
Operating Margin	-72.69%	-34.94%	-344.26%	-350.84%	-473.14%	-4205.75%
Profit Margin	-68.34%	-29.80%	-356.74%	-348.03%	-471.67%	-4094.60%
FCF Margin	-77.84%	-24.13%	-322.39%	-389.45%	-367.67%	-3568.48%
EBITDA	-6.81	-3.96	-11.64	-11.76	-9.91	-10.14
EBITDA Margin	-70.05%	-32.77%	-337.11%	-344.99%	-467.54%	-4172.52%
EBIT	-7.07	-4.23	-11.89	-11.96	-10.03	-10.22
EBIT Margin	-72.69%	-34.94%	-344.26%	-350.84%	-473.14%	-4205.75%

Updated May 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q